Clinical Trial Update: Vitamin D as an add-on Therapy With Pegylated Interferon and Ribavirin for Chronic Hepatitis c [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating Vitamin D as an add-on to pegylated interferon and ribavirin for chronic hepatitis C; the trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Copegus (ribavirin)
• Pegasys (pegylated interferon alfa-2a)
• Vitamin D (Cholecalciferol)

Snippet

Sponsor: Cairo University | Conditions: Chronic Hepatitis c | Phase 3 | Status: UNKNOWN